KP772 overcomes multiple drug resistance in malignant lymphoma and leukemia cells in vitro by inducing Bcl-2-independent apoptosis and upregulation of Harakiri.

MLA

Kater, Lisa, et al. “KP772 Overcomes Multiple Drug Resistance in Malignant Lymphoma and Leukemia Cells in Vitro by Inducing Bcl-2-Independent Apoptosis and Upregulation of Harakiri.” Journal of Biological Inorganic Chemistry (JBIC), vol. 26, no. 8, Dec. 2021, pp. 897–907. EBSCOhost, https://doi.org/10.1007/s00775-021-01900-9.

APA

Kater, L., Kater, B., Jakupec, M. A., Keppler, B. K., & Prokop, A. (2021). KP772 overcomes multiple drug resistance in malignant lymphoma and leukemia cells in vitro by inducing Bcl-2-independent apoptosis and upregulation of Harakiri. Journal of Biological Inorganic Chemistry (JBIC), 26(8), 897–907. https://doi.org/10.1007/s00775-021-01900-9

Chicago

Kater, Lisa, Benjamin Kater, Michael A. Jakupec, Bernhard K. Keppler, and Aram Prokop. 2021. “KP772 Overcomes Multiple Drug Resistance in Malignant Lymphoma and Leukemia Cells in Vitro by Inducing Bcl-2-Independent Apoptosis and Upregulation of Harakiri.” Journal of Biological Inorganic Chemistry (JBIC) 26 (8): 897–907. doi:10.1007/s00775-021-01900-9.